HCV Antibody - Immunochromatography near me in Gurgaon
Understanding HCV Antibody - Immunochromatography in Gurgaon
What is HCV Antibody - Immunochromatography in Gurgaon?
HCV Antibody - Immunochromatography test is a serological test that detects and diagnoses hepatitis C virus (HCV) infection. It is available at an affordable price in Gurgaon with Tata 1mg labs. HCV Antibody - Immunochromatography detects the antibodies that the body makes in response to HCV. HCV commonly infects the liver and if not recognized or treated timely, results in liver damage. This infection spreads when you come in contact with blood, open wounds, or body fluids of an infected person. It can also spread through sexual contact; by sharing needles, syringes, or any drug-injection equipment; or during childbirth from the mother to the baby.
The World Health Organization (WHO) recommends testing people at an increased risk of an HCV infection. Symptoms of a recent HCV infection include fever, fatigue, nausea, vomiting, decreased appetite, abdominal pain, dark urine, light-colored stools, joint pain, and jaundice. If you have come in contact with an already infected person or show any of the above symptoms, get tested with a HCV Antibody - Immunochromatography test without any delay to prevent complications.
What does HCV Antibody - Immunochromatography measure?
An HCV Antibody - Immunochromatography test determines if you have been infected by HCV and helps your doctor to guide your treatment. HCV causes liver inflammation and is classified into acute hepatitis infection and chronic hepatitis infection.
-
Acute hepatitis C: This occurs in the first six months after exposure to the hepatitis C virus. In the early stage of the infection, acute hepatitis C is mild and may cause no symptoms. For this reason, most people do not know they have this infection.
-
Chronic hepatitis C: If your body is unable to fight off the virus, you can develop a chronic hepatitis C infection. Progression from acute to chronic hepatitis C is common, occurring in about 75-85% of patients. Detecting chronic hepatitis C at the early stage is important to prevent future complications, such as liver failure, and initiate effective treatment.